This is a comprehensive, state-of-the-art guide to the diagnosis, treatment, and biology of multiple myeloma and related plasma disorders. Edited and written by a multidisciplinary group of recognized authorities from the Mayo Clinic, it presents clear guidelines on diagnosis and therapy and covers all aspects of multiple myeloma, from molecular classification and diagnosis, to risk stratification and therapy. Closely related plasma cell disorders such as solitary plasmacytoma, Waldenstrom macroglobulinemia, and light chain amyloidosis are discussed in detail as well. The book addresses often overlooked topics, including the role of radiation therapy, vertebral augmentation, and supportive care. Our understanding of this group of disorders is developing at an unprecedented rate, and Multiple Myeloma meets the need among oncologists and hematologists for a clear, timely, and authoritative resource on their biology, diagnosis, and treatment.
This book is aimed at the practitioner who is looking to put these advances into clinical context. It will serve as an up-to-date resource for treatment of myeloma and related disorders.
This book is a comprehensive source of up-to-date information on plasma cell neoplasms.
This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecu
Ravi Vij. Contemporary Management of Multiple Myeloma Contemporary Management of Multiple Myeloma ravi Vij, MD Associate Professor,. Prelims.
The only text to provide both the doctor’s and patient’s views, Understanding Multiple Myeloma gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and ...
Vasir B, Borges V, Wu Z, et al. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation. Br J Haematol 2005;129(5):687–700. Luptakova K, Rosenblatt J, Glotzbecker B, et al.
In patients with IgM MGUS, the presence of both the L265P mutation in the Myd88 gene and M protein levels above 1.5 g/dL is associated with a 45% risk of progression to Waldenström's macroglobulinemia, chronic lymphocytic leukemia or ...
The book covers the whole field of multiple myeloma, and also related diseases such as Waldemstr&öm&’s macroglobulinaemia, and incorporates both the basic science underlying the diseases and their clinical management.
Multiple Myeloma provides a comprehensive and in-depth review of this group of malignancies. This volume reviews the current literature, provides critical evaluations of the data and offers evidence-based recommendations.
On the biological side, the authors review the many important, clinically relevant discoveries that have been made in the last few years.